The confusing world of online health information

KEY TAKEAWAY: Right now, medical devices are less rigorously regulated than drugs: Only 1 percent of medical devices get FDA approval with high-quality clinical trials behind them. Even in these cases, devices typically reach the market based on data from a single small, short-term trial, Redberg wrote in a 2014 editorial in the New England Journal of Medicine, where she called for a sham control study of stents.  So what do you do if you’re a stent patient or candidate? Continue reading

Forty million Americans are currently caregivers

KEY TAKEAWAY:The massive generation of Boomers, 75 million strong today, is creating both an age wave and a caregiving crunch as it moves into its seventh decade.  The estimated economic value of family and friend caregiving is roughly $500 billion per year—3 times greater than Medicaid’s expenditures on professional long-term care. Why do pharma ignore them? Continue reading

We need prescription drugs to compensate for poor lifestyles

KEY TAKEAWAY: Nearly 40% of adults and 19% of youth are obese , the highest rate the country has ever seen in all adults, according to research released Friday by the National Center for Health Statistics.  This, of course, means that the public is going to be more dependent on prescription drugs to maintain their health at the same time they complain about big pharma. Continue reading

Lowering the fraud of online ads

KEY TAKEAWAY: Online ad fraud is shaking the online advertising industry at a time when advertisers are pouring a ton of money into the channel.  However, what’s been overlooked is that the creative for most online ads is horrible. If pharma marketers want to lower the risk of online ad fraud and improve metrics they have to do two things: ditch programmatic and improve online ad creative. Continue reading

With so much online fraud where will pharma money go?

KEY TAKEAWAY: According to Fierce Pharma “Outcome Health went into crisis communications mode after a Wall Street Journal article last week said the fast-growing pharma services company had misled its advertisers. Within hours, the company posted a letter to clients—on its website and social media—outlining in detail how it was addressing the problem”.  Just pile on the fraud! Continue reading